February 19, 2001 - 18 Anti-Smoking Drug Patients Die
The Medicines Control Agency, which is conducting an intensive monitoring program on Zyban, has received reports of 3,457 patients complaining of adverse reactions. The safety of the anti-smoking drug is under investigation, since 18 people had allegedly died while taking the drug.
Since it became available on a prescription basis last June, 270,000 smokers in Britain have been given courses of the drug. Zyban inhibits the craving for cigarettes. Although most side effects are mild, like insomnia, rashes and dry mouth, 73 people might have had seizures, including a Manchester ambulance driver who crashed when responding to an emergency call.
However, there is no medical evidence that Zyban contributed to patients' deaths because all of them smoked and thus, were in a high-risk group. A Department of Health spokesman said: "We have asked GPs to report all suspected adverse reactions. The drug has been widely prescribed and we were expecting a large number of reports."
GlaxoSmithKline, the manufacturer of the drug, said it took reports of adverse reactions to the drug very seriously but found no evidence it was dangerous.
If you or a loved one has suffered an injury as a result of taking any drug or supplement, call Littman & Babiarz, Attorneys at Law now at 607-277-7527 or CLICK HERE TO SUBMIT A SIMPLE CASE FORM. The initial consultation is free of charge, and if we agree to review your case, we will work on a contingent fee basis, which means we get paid for our services only if there is a monetary award or recovery of funds. Don't delay! You may have a valid claim and be entitled to compensation for your injuries, but a lawsuit must be filed before the statute of limitations expires.
<< back
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.
